Percutaneous endoscopic gastrostomy with jejunal extension versus direct percutaneous endoscopic jejunostomy: patient-related outcomes and complications
Clinical Endoscopy · 30.07.2026 · 59 (4) · 642-652
DOI: 10.5946/ce.2025.401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endoscopy, erschienen am 30.07.2026. Verfasst von Giel J L van Neerven und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background/Aims: Percutaneous endoscopic gastrostomy with jejunal extension (PEG-J) and direct percutaneous endoscopic jejunostomy (D-PEJ) are used for jejunal feeding or administration of levodopa-carbidopa intestinal gel in patients with Parkinson’s disease. PEG-J is currently preferred because it is technically less challenging to insert. However, comparative studies are scarce, and data on patient-reported outcomes (PROMs) are limited.
Methods
In this retrospective study conducted at a referral hospital, clinical experience, adverse events (AEs), and PROMs associated with both techniques were evaluated.
Results
Ninety-three patients underwent PEG-J and/or D-PEJ placement between January 1, 2010, and July 1, 2022. Patients with PEG-J required significantly more re-endoscopies per tube-year than those with D-PEJ (0.63 [standard deviation, SD, 0.72] vs. 0.27 [SD 0.50]). A total of 76.8% of PEG-J patients underwent at least one re-endoscopy (range, 0–3.85 per year), primarily due to dislocated jejunal extensions (77.4%). Tube-related AEs (including dislocation, occlusion, perforation, and ulceration) occurred significantly more often after PEG-J insertion (76.7% vs. 25.9%). Forty-five patients (48%) completed the PROM questionnaire. No statistically significant differences were found in quality of life. However, D-PEJ patients reported significantly more tube-related pain (44.4% vs. 15.9%).
Conclusions
D-PEJ represents a viable alternative to PEG-J in experienced centers and should be considered when frequent complications with jejunal extensions occur.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
- Department of Neurology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
Zitieren
APA
van Neerven, G. J. L., Gilissen, E. H. T., Gielen, R., Baars, A., Stelten, B. M. L., Flink, H., & Gilissen, L. P. L. (2026). Percutaneous endoscopic gastrostomy with jejunal extension versus direct percutaneous endoscopic jejunostomy: patient-related outcomes and complications. Clinical Endoscopy, 59(4), 642-652. https://doi.org/10.5946/ce.2025.401
Vancouver
van Neerven GJL, Gilissen EHT, Gielen R, Baars A, Stelten BML, Flink H, et al. Percutaneous endoscopic gastrostomy with jejunal extension versus direct percutaneous endoscopic jejunostomy: patient-related outcomes and complications. Clinical Endoscopy. 2026;59(4):642-652. doi:10.5946/ce.2025.401
BibTeX
@article{vanNeerven2026,
author = {van Neerven, Giel J L and Gilissen, Eline H T and Gielen, Roos and Baars, Arlinda and Stelten, Bianca M L and Flink, Hajo and Gilissen, Lennard P L},
title = {Percutaneous endoscopic gastrostomy with jejunal extension versus direct percutaneous endoscopic jejunostomy: patient-related outcomes and complications},
journal = {Clinical Endoscopy},
year = {2026},
volume = {59},
number = {4},
pages = {642--652},
doi = {10.5946/ce.2025.401}
}
EUVIMED